Vimarsana
Biggest News Aggregation in the World

Page 46 - Smith Kline News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Smith Kline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Smith Kline Today - Breaking & Trending Today

A new vaccine joins the fall lineup - Vimarsana News

A new vaccine joins the fall lineup

RSV stands for respiratory syncytial virus and, like the flu, it's a seasonal illness that crops up in the fall and winter. It can be especially dangerous for the very young and those over 60.

Vaccines Market Size To Reach USD 153.49 Billion, With at a 14.1% CAGR between 2022 to 2028 - Vimarsana News

Vaccines Market Size To Reach USD 153.49 Billion, With at a 14.1% CAGR between 2022 to 2028

/PRNewswire/ -- According to a comprehensive research report by Brandessence Market Research (BMRC), "Vaccines Market Size, Share, Companies & Trends Analysis...

Barbara Zehentner, Chief Operating Officer - Molecular Testing Labs - Vancouver Business Journal - Vimarsana News

Barbara Zehentner, Chief Operating Officer - Molecular Testing Labs - Vancouver Business Journal

Barbara Zehentner is inspired by the power of science, continuous learning, teamwork, and technological innovation to transform lives. Because of this,

Source: vbjusa.com
LIB Therapeutics Appoints David Cory as Chief Executive Officer as Lead Clinical Programs Achieve Ph - Vimarsana News

LIB Therapeutics Appoints David Cory as Chief Executive Officer as Lead Clinical Programs Achieve Ph

-- Industry veteran brings more than 30 years of operational experience, in large pharma and emerging stage biotech, private and public companies, with extensive commercial experience and an established track record of financing in the capital markets-- Lerodalcibep, a novel, next generation PCSK9 inhibitor and the...

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies - Vimarsana News

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

Objective To systematically assess credibility and certainty of associations between cannabis, cannabinoids, and cannabis based medicines and human health, from observational studies and randomised controlled trials (RCTs). Design Umbrella review. Data sources PubMed, PsychInfo, Embase, up to 9 February 2022. Eligibility criteria for selecting studies Systematic reviews with meta-analyses of observational studies and RCTs that have reported on the efficacy and safety of cannabis, cannabinoids, or cannabis based medicines were included. Credibility was graded according to convincing, highly sug...

Source: bmj.com